Cellular/Molecular Glutamate Spillover in the Striatum Depresses Dopaminergic Transmission by Activating Group I Metabotropic Glutamate by Hui Zhang & David Sulzer
Cellular/Molecular
GlutamateSpilloverintheStriatumDepressesDopaminergic
TransmissionbyActivatingGroupIMetabotropicGlutamate
Receptors
HuiZhang1andDavidSulzer1,2,3
Departmentsof 1Neurologyand 2Psychiatry,ColumbiaUniversity,NewYork,NewYork10032,and 3DepartmentofNeuroscience,NewYorkState
PsychiatricInstitute,NewYork,NewYork10032
Corticalglutamateandsubstantianigradopamine(DA)afferentsconvergeontothedendriticspinesofmediumspinyneurons(MSNs)in
the striatum where they act to modulate motor and cognitive functions. The released DA spills over from its synapse and is thought to
regulateglutamatergicinputbyactingondistalDAreceptorslocatedoncorticostriatalaxonterminals.BymonitoringevokedDArelease
directly using fast-scan cyclic voltammetry, we report a reciprocal modulation by glutamate spillover on evoked striatal DA release,
inducedbyeitherglutamateuptakeblockadeorhigh-frequencystimulationofcorticostriataltracts.Wedemonstratethatthismodula-
tionisattributabletotheactivationofgroupImetabotropicglutamatereceptors.Thus,underconditionsinwhichglutamateescapesthe
confinesofitssynapse,itcanelicitthepresynapticsuppressionofdopaminergicneurotransmission.
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Introduction
High-affinity uptake by excitatory amino acid transporters
(EAATs)restrictsthediffusionofsynapticallyreleasedglutamate
beyond the confines of its synapse (Diamond and Jahr, 1997).
Glutamate spillover, induced by pharmacological inhibition of
EAATs, modifies synaptic transmission in the cerebellum and
hippocampus (Mitchell and Silver, 2000; Semyanov and Kull-
mann, 2000; Turecek and Trussell, 2000; Brasnjo and Otis, 2001;
Diamond, 2001). Whereas direct synaptic contacts between ni-
grostriatal dopaminergic and corticostriatal glutamatergic axon
terminals have not been observed in the striatum, their boutons
closely converge onto the dendritic spines of medium spiny neu-
rons (MSNs) (Nirenberg et al., 1996). Dopamine (DA) spillover
from the nigrostriatal synapse not only activates receptors on
MSNs several micrometers away (Garris et al., 1994; Gonon,
1997; Gonon et al., 2000) but may also activate presynaptic DA
receptors on neighboring glutamatergic corticostriatal afferents
(Wang and Pickel, 2002). This presynaptic action has been re-
ported in some studies to regulate the release of glutamate in the
striatum (Cepeda et al., 2001; Tang et al., 2001). A role for gluta-
matespilloverandareciprocalpresynapticmodulationofnigro-
striatal DA transmission, however, has not been determined.
In the present study, we used EAATs blockers or high-
frequency stimulation (HFS) of corticostriatal tracts to enhance
the synaptic overflow of glutamate and monitor its effect on
evoked DA release in the mouse striatal slice with fast-scan cyclic
voltammetry. The results showed that glutamate spillover inhib-
its evoked DA release by acting on metabotropic glutamate 1
receptors (mGluR1).
MaterialsandMethods
Animals and striatal slice preparation. Two- to 5-month-old male
C57BL/6 mice and mGluR5-deficient mice (B6,129-Gprcle
tm1Rod) were
obtainedfromTheJacksonLaboratory(BarHarbor,ME).Theuseofthe
animals followed the National Institutes of Health guidelines and was
approved by the Institutional Animal Care and Use Committee of Co-
lumbia University.
Miceweredecapitatedwithoutanesthesia.Coronalstriatalbrainslices
at 300 m (bregma 1.54 to 0.62 mm) (Franklin and Paxinos, 1997)
werepreparedonavibratome.Sagittalstriatalslices,alsoat300m,were
used for the HFS experiments. The slices were allowed to recover for 1.5
hr at room temperature in a holding chamber containing oxygenated
artificialCSF(ASCF)andthenplacedinarecordingchambersuperfused
(1 ml/min) with ACSF (in mM: 125 NaCl, 2.5 KCl, 26 NaHCO3, 2.4
CaCl2, 1.3 MgSO4, 0.3 KH2PO4, and 10 glucose) at 36°C.
D,L-Threo--hydroxyaspartate (THA), D,L-threo--benzyloxyaspartate
(TBOA), S--methyl-4-carboxyphenylglycine (MCPG), 1-aminoin-
dan-1,5-dicarboxylic acid (AIDA), 2-methyl-6-(phenylethynyl)pyridine
(MPEP), (S)-3,5-dihydroxyphenylglycine (DHPG), 2R,4R-4-amino
pyrrolidine-2,4-dicarboxylate[(2R,4R)-APDC],L-2-amino-4-phospho-
nobutyric acid (L-AP-4), (RS)-2-chloro-5-hydroxyphenylglycine
(CHPG), 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX), D()-2-
amino-5-pho-sphonopentanoic acid (D-AP-5), CGP52432, 8-cyclo-
pentyl-1,3-dipro-pylxanthine (DPCPX), 4-(2-[7-amino-2-(2-furyl)[1,2,4]
triazolo[2,3-a][1,3,5]triazin-5-ylamino] ethyl)phenol (ZM241385),
AM281, WIN55,212-2, 2-aminoethoxydiphenylorane (2APB), and
cyclopiazonic acid (CPA) were obtained from Tocris Cookson (Balwin,
MO). Dihydrokainate (DHK), GABAzine (SR95531), atropine,
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chloride (Che) were from Sigma (St. Louis,
MO). Xestospongin C (XeC) was from Calbio-
chem(SanDiego,CA).Alldrugsattheconcen-
trationuseddidnotaltertheelectrodesensitiv-
ity.Thedrugsweredilutedfromfrozenaliquots
immediately before use and were applied
through bath application. Ultrapure water
(Nanopure; Barnstead, Dubuque, IA) was used
in all solutions.
Electrochemical recordings. Electrochemical
recordings and electrical stimulation were
adaptedfromSchmitzetal.(2001).Briefly,disk
carbonfiberelectrodesof5mdiameterwitha
freshly cut surface were placed into the dorsal
striatum 50 m below the exposed surface.
For cyclic voltammetry (CV), a triangular volt-
age wave (400 to 900 mV at 280 V/sec vs
Ag/AgCl)wasappliedtotheelectrodeevery100
msec. For amperometry, a constant voltage of
400 mV was applied via an Axopatch 200B
(Axon Instruments, Foster City, CA). Current
was recorded with an Axopatch 200B amplifier
with a low-pass Bessel filter setting at 10 kHz,
digitized at 25 kHz (ITC-18 board; InstruTech,
Great Neck, NY). Triangular wave generation
and data acquisition were controlled by a per-
sonal computer running a locally written (Dr.
E. Mosharov, Columbia University, New York,
NY) IGOR program (WaveMetrics, Lake Os-
wego, OR). Striatal slices were electrically stim-
ulatedbyanIso-Flexstimulusisolatortriggered
byaMaster-8pulsegenerator(A.M.P.I.,Jerusa-
lem, Israel) using a bipolar stimulating elec-
trode placed at a distance of 100 m from the recording electrode.
Background-subtracted cyclic voltammograms served for electrode cali-
brationandtoidentifythereleasedsubstance.Thecurrentwasconverted
toconcentrationbasedonacalibrationinACSFaftertheexperiment.In
some cases, after using CV to confirm the identity of DA, we switched to
amperometry to increase temporal and detection sensitivity.
The slices were equilibrated in the recording chamber for 20 min
before experiments were conducted. The slices were stimulated every 2
min by a single-pulse stimulus in the dorsal striatum, and experiments
were generally initiated after five stimuli to confirm a consistent and
robust response.
Data analysis and statistics. The drugs used in this study mainly af-
fected the amplitude of the evoked DA response and usually attained a
maximal effect within 10 min. Therefore, the change of DA amplitude
was determined by comparing DA release before and after 10 min appli-
cation of the agents, unless otherwise specified. This is expressed as a
percentage of the average amplitude of the two postdrug responses di-
vided by the average amplitude of the two predrug responses.
Experimental values in the text and in the figures are mean  SEM.
The two-tailed Student’s t test was used for paired data, and one-way
ANOVA followed by Dunnett’s test was used for group data (GraphPad
Software, San Diego, CA). The difference was considered significant at
levels of p  0.05.
Results
InhibitionofevokedDAreleasebyEAAT blockers
To investigate whether the overflow of endogenous glutamate
modulatesevokedDArelease,weappliedasingle-pulseelectrical
stimulus every 2 min in the dorsal striatum of acutely prepared
corticostriatalslicestoelicitthereleaseofbothDAandglutamate
from nigrostriatal and corticostriatal afferents. DA release was
monitoredbyCV(Schmitzetal.,2001)throughouttheprotocol.
Undercontrolconditions,therewasaslightrundownduringthe
20minexperimentduration(55%;n4).Bathapplicationof
theEAATblockerTHA(100M)(Arrizaetal.,1994)suppressed
evoked DA release by 4 min and reached a maximal inhibition of
33% of control levels at 10 min (Fig. 1a). A concentration–re-
sponse curve for THA revealed an EC50 of 60 M (Fig. 1c), and
300MTHAsuppressedevokedDAreleaseby343.7%(n4)
(Fig. 1b,c). Similarly, the THA analog TBOA (50 M) a nonspe-
cific EAAT blocker but one of the most potent nonsubstrate in-
hibitors of EAAT2 (Shimamoto et al., 1998), elicited a similar
reduction of evoked DA release (44  7.6%; n  7; not statisti-
cally different from THA) (Fig. 1d).
The five high-affinity sodium-dependent EAA transporters
that have been cloned from human tissue are termed EAAT1 to
EAAT5 (Arriza et al., 1994; Fairman et al., 1995). Three homol-
ogous transporter proteins have been identified in rodents:
GLAST [for glutamate/aspartate transporter (EAAT1)], GLT1
[for glutamate transporter-1 (EAAT2)], and EAAC1 (EAAT3)
(Pines et al., 1992; Storck et al., 1992). In the rat striatum, GLT1
and GLAST are expressed in astrocytes, and EAAC1 is expressed
inneurons(Rothsteinetal.,1994;Lehreetal.,1995).Toestimate
the relative contribution of glial and neuronal glutamate trans-
porters to the DA depression, we compared the effects of THA
andTBOAwiththeeffectofDHK,aspecificuptakeinhibitorfor
GLT1 subtype (Rothstein et al., 1994). DHK (300 M) elicited a
DAdepression(457.1%;n5)similartoTBOA.Therefore,it
seems that the DA depression by glutamate overflow was attrib-
utable mainly to the suppression of the glial glutamate trans-
porter GLT1.
TheeffectsofbothTBOAandDHKoninhibitionofevoked
DA release fully recovered after a 20 min washout, whereas
there was a partial recovery from the effect of THA (data not
shown).
Figure1. InhibitionofevokedDAreleasebyEAATblockers.a,InhibitionofevokedDAreleaseby100MTHA.Voltammetric
responsesobtainedinastriatalsliceduringsevensequentialstimuliat2minintervals.THA(100M)wasaddedtotheperfusion
mediumimmediatelyafterthesecondstimulus.b,ThetimecourseoftheTHA(300M)effectonevokedDArelease(n8,THA;
n  4, control, i.e., perfusion medium; *p  0.05 compared with respective control values by Student’s t test). c,
Dose–responsecurveofTHA(n4).d,InhibitionofevokedDAreleasebydifferentEAATblockers.THA,300M;TBOA,
50M;DHK,300M(n4–7).
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activationof mGluRs
The depression of stimulated DA release by THA was not medi-
ated by ionotropic glutamate receptors (iGluRs), because the
combination of the NMDA receptor antagonist D-AP-5 (50 M)
and the AMPA/kainate receptor antagonist CNQX (10 M) did
not occlude the THA effect (n  5). In contrast, the broad-
spectrum mGluR antagonist MCPG (300 M) potently blocked
the THA-induced inhibition of evoked DA release (n  4) (Fig.
2). Neither D-AP-5 plus CNQX nor MCPG alone had any signif-
icant effect on evoked DA release (data not shown).
THAreducedevokedDAreleasebyactivatinggroup
I mGluRs
To date, eight members of the mGluRs family have been identi-
fied.Thesearesubdividedintothreegroupsonthebasisofamino
acid sequence homology, signal transduction mechanisms, and
pharmacologicalprofiles(ConnandPin,1997).Weusedspecific
ligands to identify which mGluRs mediated the THA effect on
evoked DA release. The selective group I antagonist AIDA (300
M) blocked the depression of DA release by THA (n  4) (Fig.
3a). Consistent with an action mediated by group I mGluRs, the
group I mGluR agonist DHPG produced a dose-dependent re-
ductionofDAreleasethatwassimilarindurationandmagnitude
to THA, reaching a maximal inhibition of 40% of control levels.
The depression recovered after a 30 min washout. No significant
inhibition of stimulated DA release was observed with either the
group II mGluR agonist (2R,4R)-APDC (20 or 50 M)o rt h e
groupIIImGluRagonist L-AP-4(100or300M)(Fig.3b).AIDA
alonedidnotenhanceDArelease(14.33.7%ofcontrol;n
4),indicatingthattherewasnotonicactivationofmGluRsonthe
dopaminergic transmission in the preparation.
Group I mGlu receptors comprise mGluR1 and mGluR5. To
determinewhichsubtypewasinvolved,weusedbothpharmaco-
logical tools and mGluR5-deficient mice. The mGluR5-specific
agonist CHPG (500 M) had no effect on evoked DA release
(3.6  5.7%; n  4). Consistently, the mGluR5-specific antag-
onist MPEP (20 M) itself had no effect on evoked DA release
(0.3  0.3%; n  4) and did not block the effect of DHPG
(38.2  3%; n  6). Furthermore, mGluR5-deficient mice ex-
posedtoDHPGexhibitedsimilarDAdepression(39.32.7%;
n  4) (Fig. 3c). We therefore conclude that the inhibition of
evoked DA release was attributable to the activation of mGluR1.
DHPG-induceddepressionofevokedDAreleasewas
mediatedbymobilizationofinternalCa
2stores
Group I mGluRs are phospholipase C (PLC) coupled receptors
(Pin and Duvoisin, 1995) that stimulate phosphoinositide (PI)
hydrolysis and diacylglycerol (DAG) generation. To gain insight
into the mechanisms involved in the depression of DA release by
mGluR1 activation, we first measured evoked DA release after
exposing slices to U73122 (10 M for 20 min), a specific antago-
nistofPLC.U73122itselfhadnoeffect(6.52.1%;n6)but
completely blocked the effect of DHPG (4.7  6.0%; n  7)
(Fig. 4). Inhibition of protein kinase C (PKC) by Che (20 M),
which is activated downstream of PI hydrolysis, did not abolish
DHPG-induced depression (42  2%; n  4).
Because calcium release from intracellular stores can regulate
neurotransmitter release and recent studies report the involve-
ment of inositol-1,4,5-trisphosphate (IP3) in mGluR-induced
Ca
2 mobilization (Finch and Augustine, 1998; Morikawa et al.,
2000), we were interested in determining whether internal Ca
2
mobilization was involved. For example, it may be that the pro-
longed treatment with DHPG depletes internal Ca
2 stores on
the DA terminals and therefore decreases evoked DA release.
Pretreatment of slices with CPA (20 M, 20 min), which depletes
intracellular Ca
2 stores by blocking the ATPase that mediates
Ca
2 uptake (Seidler et al., 1989; Fiorillo and Williams, 1998),
completely blocked DHPG-induced depression (9.6  3.0%;
n10).SimilarresultswereobtainedbyinhibitingIP3receptors.
Application of the membrane-permeable IP3 receptor inhibitor
2APB (100 M) completely prevented the inhibition of evoked
DA release by DHPG (8.3  5.2%; n  3). These results were
confirmed by a more specific and potent membrane-permeable
IP3 receptor inhibitor, XeC (3 M; 9.8  6%; n  5) (Fig. 4)
(Gafni et al., 1997). We further investigated the downstream
mechanisms by applying apamin (0.3 M), a blocker of calcium-
activated potassium channels. Although apamin itself had no ef-
fect on evoked DA release (7.1  5.2%; n  7), it blocked the
DHPG-inducedinhibitionofevokedDArelease(12.05.0%;
n  7). Together, these results suggest that intracellular Ca
2
mobilizationandactivationofapamin-sensitivepotassiumchan-
nels (Fiorillo and Williams, 1998) underlie the depression of DA
release induced by DHPG.
DHPGmayactdirectlyonpresynapticmGluR1on
DA terminals
Our results clearly demonstrated that activating mGluR1 de-
pressed evoked DA release. At many central synapses, release
activity is thought to be inhibited by various neuromodulators
acting at presynaptic receptors located on terminals (Wu and
Saggau, 1997). To determine whether the DHPG-induced inhi-
bitionofevokedDAreleasewasmediatedbyadirectactivationof
the mGluR1 on the DA terminals or by an indirect mechanism
involving other transmitters, e.g., acetycholine (ACh), we per-
formedaseriesofexperimentsusingvariousantagonists.Neither
the GABAa receptor antagonist GABAzine (10 M) nor the
GABAb receptor antagonist CGP 52432 (10 M), blocked the
effect of DHPG (35  1.6 and 39  4.3%, respectively) (Fig.
5a). Similarly, neither the adenosine A1 receptor antagonist
DPCPX (1 M) nor the A2a receptor antagonist ZM241385 (3
M) blocked the effect of DHPG (32  1.8 and 35  4.0% ,
respectively) (Fig. 5b). The antagonists themselves had no effect
on evoked DA release, indicating an absence of GABA or adeno-
sine tone in the slice preparation.
Consistent with the literature (Kudernatsch and Sutor, 1994;
Zhouetal.,2001),themAChRantagonistatropine(2M)hadno
Figure2. InhibitionofevokedDAreleasebyTHAwasattributabletoactivationofmGluRs.
The combination of the NMDA receptor antagonist D-AP-5 (50 M) and the AMPA/kainate
receptorantagonistCNQX(10M)didnotoccludetheresponsetoTHA(300M),whereasthe
broad-spectrummGluRantagonistMCPG(300M)blockedTHAinhibitionofevokedDArelease
(n4–5;**p0.01comparedwithTHA,byone-wayANOVAfollowedbyDunnett’stest).
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nitcotinic ACh receptor (nAChR) antago-
nistmecamylamine(2M)severelyinhib-
ited evoked DA release (55  3.6%; n 
4).Nevertheless,200MDHPGcausedan
additional inhibition (32.0  3.1%; n 
5) in mecamylamine-treated slices. Atro-
pine and mecamylamine together also
failed to block the effect of DHPG (n  5)
(Fig. 5c). To exclude an indirect effect at-
tributabletosomecomplicatedinteractive
actions between the receptors, we finally
applied a mixture containing all of the an-
tagonists otherwise applied separately (50
MD -AP-5, 10 M CNQX, 10 M GABA-
zine, 10 M CGP52432, 1 M DPCPX, 3
M ZM241385, 1 M atropine, and 2 M
mecamylamine). The mixture itself inhib-
ited evoked DA release by 62  1.8% at-
tributable to the action of mecamylamine.
However, it did not abolish the inhibitory
effect of DHPG on evoked DA release
(40  6.0%; n  4) (Fig. 5d). The mixture also did not block the
effect of THA (data not shown).
Activation of postsynaptic mGluRs, for example, those ex-
pressedinMSNs(Testaetal.,1998)andlargeapical(LA)cholin-
ergic interneurons (Takeshita et al., 1996), could retrogradely
influence presynaptic functions mediated by the cannabinoid
CB1 receptors (CB1R) (Kreitzer and Regehr, 2001; Robbe et al.,
2002). The CB1R antagonist AM281 (3 M) did not abolish the
effectofDHPG.AM281itselfhadnoeffectonevokedDArelease.
Consistently, the CB1R agonist WIN55,212-2 (15 M) had no
effect on evoked DA release (Fig. 6).
Although we cannot completely exclude the possibility of an
indirect pathway, our results suggest that glutamate may act di-
rectly on the mGluR1 on DA terminals to depress evoked DA
release (see Discussion)
InhibitionofevokedDAreleaseby HFS
The efficacy of 100 M THA (Fig. 1a) suggests that even a rela-
tively modest blockade of glutamate transporters leads to a sig-
nificant activation of mGluR1. We were interested in investigat-
ing whether trains of HFS such as those used in inducing striatal
long-termpotentiationorlong-termdepressioncouldcauseglu-
tamate spillover and in turn depress evoked DA release. Because
local HFS depleted DA completely and interfered with monitor-
ing evoked DA release (data not shown), we performed these
experiments in sagittal slice preparations encompassing a more
intact corticostriatal glutamatergic projection. Fiber tracts in the
corpus callosum (CC) were stimulated by HFS [six trains of 100
pulses(100Hz)at10secintervals]toinduceglutamatereleasein
thestriatum,whereasevokedDAreleasewasrecordedatleast500
mawayfromtheCC(Fig.7a).TheHFSdidnotelicitdetectable
releaseofDAattherecordingsite.In9of16slices,weobserveda
depressionofevokedDAreleasewithin1minafterHFS,reaching
a maximum inhibition of 30  4% by 5 min with a nearly com-
plete recovery within 11 min (Fig. 7b). The development of this
depression within 5 min after HFS also strongly argued against a
role for undetectable depletion of DA by HFS (if HFS at the CC
had depleted DA at the recording site, evoked DA release should
only show recovery after HFS). In addition, in MCPG perfused
slices (n  4) (Fig. 7b) or coronal slices (n  12), we never
observed a depression of evoked DA release by HFS. The combi-
nation of the iGluRs antagonists (10 MD -AP-5 plus 10 M
CNQX) had no effect on DA depression by HFS (data not
shown).
Discussion
Ithasbeensuggestedthat,aftertheaccumulationofglutamatein
the synaptic cleft, glutamate spillover can reach perisynaptic re-
ceptors and trigger the mGluR-mediated responses. The present
results are the first to demonstrate that spillover of glutamate
inhibits evoked DA release in the striatum and that this effect is
mediated via activation of group I mGluRs.
InhibitionofevokedDAreleasebyglialglutamate
transporterblockersviaactivationof mGluR1
The level of extrasynaptic glutamate appears to be regulated via
clearance by EAATs (Diamond and Jahr, 1997), particularly by
Figure3. THAreducedevokedDAreleasebyactivatingmGluR1.a,ThegroupImGluRantagonistAIDA(300M)blockedthe
inhibitionbyTHA(300M)onevokedDArelease(n4;**p0.01comparedwithTHAbyStudent’sttest),whereasAIDAitself
hadnoeffect.b,ThegroupImGluRagonistDHPG(100and200M)andnotthoseforgroupII(APDC,20and50M)andgroup
IIImGluR(L-AP-4,100and300M)inhibitedevokedDArelease(n4–10;**p0.01comparedwithcontrolbyone-way
ANOVA followed by Dunnett’s test). c, The mGluR5 agonist CHPG (500 M) had no effect on evoked DA release. The mGluR5
antagonistMPEP(20M),aswellaslackofthereceptorinmGluR5-deficientmice,didnotblocktheinhibitionbyDHPGonevoked
DArelease(n4–6;**p0.01comparedwithcontrolbyone-wayANOVAfollowedbyDunnett’stest).
Figure4. InhibitionofevokedDAreleasebyDHPGismediatedbymobilizinginternalCa
2
storesandactivationofanapamin-sensitivepotassiumchannel.Blackbars,(1EvokedDA
releaseafter/EvokedDAreleasebeforeapplicationoftheagent)100%;hatchedbars,(1
Evoked DA release in the presence of 200 M DHPG and the agent/Evoked DA release in the
presenceoftheagent)100%.InhibitionofPLCby10MU73122completelyblockedthe
inhibitionbyDHPGonevokedDArelease.InhibitingPKCbyChe(20M)didnotblocktheeffect
ofDHPG,whereasdepletionofintracellularCa
2storebyCPA(20M,20min)orantagonizing
IP3receptorby3MXeCor100M2APBblockedtheeffectofDHPGcompletely.Theeffectof
DHPG was blocked by apamin (0.3 M)( n  3–10; **p  0.01 compared with control by
one-wayANOVAfollowedbyDunnett’stest).
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GLT1 and GLAST and the neuronal transporter EAAC1 are ex-
pressed in the rat striatum (Rothstein et al., 1994; Lehre et al.,
1995),withGLT1beingthedominantform(Lievensetal.,2001).
Using EAAT blockers to enhance extrasynaptic glutamate
concentration,wefoundthatglutamatecouldspilloverfromthe
synaptic cleft to depress evoked DA release. Selective blockade of
EAATsindicatedthatinhibitionofevokedDAreleasewasmainly
mediatedthroughGLT1(EAAT2)blockade.Thus,theregulation
of extrasynaptic glutamate in the striatum is mostly attributable
to uptake by glia.
Consistent with these findings, the depression of evoked DA
release by glutamate spillover was mimicked by the direct activa-
tion of mGluR1 by its specific agonist DHPG. We were con-
cerned, however, that because group I mGluRs are easily desen-
sitized (Gereau and Heinemann, 1998; Rodriguez-Moreno et al.,
1998; Alagarsamy et al., 2001), this effect by DHPG may not
reflect the normal function of mGluR1. For instance, both
nAChR agonists and antagonists depress evoked DA release in
striatalslices(Zhouetal.,2001).Inthiscase,thenAChRagonists
are thought to desensitize the receptors, whereas the antagonists
inhibit ongoing low-level nAChRs activation. Thus, the normal
function of tonic nAChR activation appears to stimulate DA re-
lease. Similarly, if tonic mGluR1 activation is excitatory for DA
release, bath application of DHPG might depress DA release via
desensitization.Wefound,however,thatAIDA,agroupImGluR
antagonist, had no effect on evoked DA release, indicating that
there was no tonic activation of mGluR1. In addition, glutamate
spillover caused by HFS, which should imitate the physiological
effectsofstronghigh-frequencycorticalinputs,depressedevoked
DA release. Moreover, group I mGluRs have been shown to ex-
hibit a dual action on glutamate release in hippocampal slices,
switching from facilitation to inhibition during receptor desen-
Figure5. InhibitionofevokedDAreleasebyDHPGmaybemediatedbyactingdirectlyon
mGluR1onDAterminals.a,NeithertheGABAareceptorantagonistGABAzine(10M)northe
GABAbreceptorantagonistCGP52432(10M)couldblocktheeffectofDHPG.b,Neitherthe
adenosineA1receptorantagonistDPCPX(1M)northeA2areceptorantagonistZM241385(3
M)couldblocktheeffectofDHPG.c,NetherthemAChRantagonistatropine(2M)northe
nAChRs antagonist mecamylamine (2 M) or the combination of both blocked the effect of
DHPG. d, A mixture containing all of the antagonists (50 MD -AP-5, 10 M CNQX, 10 M
GABAzine, 10 M CGP52432, 1 M DPCPX, 3 M ZM241385, 1 M atropine, and 2 M
mecamylamine)failedtopreventtheDAdepressioninducedbyDHPG.Blackbars,(1Evoked
DA release after/Evoked DA release before application of the agent)  100%; hatched bars,
(1EvokedDAreleaseinthepresenceof200MDHPGandtheagent/EvokedDAreleaseinthe
presence of the agent)  100% (n  3–7; **p  0.01 by one-way ANOVA followed by
Dunnett’s test for the agents indicated vs control for the respective group; black bars, in the
absenceofDHPG;hatchedbars,inthepresenceofDHPG).
Figure6. InhibitionofevokedDAreleasebyDHPGwasnotCB1Rmediated.TheCB1Rantag-
onistAM281(3M)hadnoeffectonevokedDAreleaseanddidnotabolishtheeffectofDHPG.
TheCB1RagonistWIN55,212-2(15M)hadnoeffectonevokedDArelease(n4–8).
Figure 7. Inhibition of evoked DA release by HFS. a, Diagram of HFS and electrochemical
recordingelectrodeplacement.STR,Striatum;Hip,hippocampus;CC,corpuscallosum.HFS,Six
trainsof100pulses(100Hz)at10secintervals.b,TimecourseofnormalizedevokedDArelease
after HFS. HFS depressed evoked DA release (filled circles; n  9), whereas 300 M MCPG
blockedthiseffect(opencircles;n4).Inset,CVrecordingsatdifferenttimepointsasindi-
catedbya–c.
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sibility, we pretreated slices with the mGluR antagonist MCPG
(300 M, 2 hr) to remove any potential desensitization during
slice preparation. We did not observe any facilitation by applica-
tionofDHPG,orEAATinhibitors,orHFS(datanotshown).We
thereforeconcludethatmGluR1activationactstoinhibitevoked
DA release.
DHPG-inducedinhibitionofevokedDAreleaseismediated
bythemobilizationofinternalCa
2stores
TheactivationofPI-linkedgroupImGluRsleads,viaPLC,tothe
hydrolysis of phosphatidylinositol-4,5-bisphosphate into two
secondmessengers,DAGandIP3.DAGactsbystimulatingPKC,
whereas IP3 induces Ca
2 release from intracellular Ca
2 stores
(Pin and Duvoisin, 1995). We found that, whereas inhibition of
PKC failed to block the effect of DHPG on evoked DA release,
depletion of intracellular Ca
2 stores by CPA blocked the effect.
Thus, the effect of DHPG was mediated through Ca
2
mobilization.
This mGluR1-mediated inhibition through Ca
2 mobiliza-
tion could be attributable to either depletion of internal calcium
stores in the terminals by the prolonged treatment with DHPG
(and therefore decreased evoked transmitter release) or activa-
tion of Ca
2-dependent pathways that inhibit DA release, for
example, by activating Ca
2-dependent potassium currents. Be-
cause CPA itself had no effect on evoked DA release, it is likely
that activation of mGluR1 depresses evoked DA release by acti-
vating Ca
2-dependent pathways. The involvement of Ca
2-
dependent potassium currents was confirmed by the effects of
apamin. Thus, the inhibition of evoked DA release by mGluR1
activation involves Ca
2-activated potassium channels. Never-
theless, given the long-lasting (several minutes) depression of
evoked DA release by HFS (see below), and noting that mGluR1
can modulate Ca
2 channels (McCool et al., 1998; Stefani et al.,
1998; Anwyl, 1999; Faas et al., 2002), our results do not rule out
the possibility that mGluR1 may exert additional effects on
evoked DA release by inhibiting presynaptic Ca
2channels.
IsDAdepressionmediatedbyadirectpresynaptic
mechanismorbyanindirectcircuit mechanism?
Although the voltammetric technique records presynaptic re-
leased DA directly, our data do not rule out a presynaptic effect
mediated by other transmitters or a retrograde signal that might
mediate the effect of mGluR1 activation. In addition to the D2
autoreceptor, there are various heteroreceptors expressed on DA
terminals, including nAChRs (Wonnacoott et al., 2000) and
GABAbR(Chararaetal.,2000;Schmitzetal.,2002),andmGluRs
are expressed in MSNs (Testa et al., 1998; Pisani et al., 2000) and
LA cholinergic interneurons (Takeshita et al., 1996), in addition
to DA terminals (Paguet and Smith, 2003). Therefore, DHPG
couldexhibititseffectindirectlythroughGABAorAChbyacting
onMSNorLAneurons.Forexample,activationofmGluR1may
depolarizethemembrane,contributingtoanincreasedfiringrate
of these neurons and a subsequent augmented release of ACh
and/or GABA. To rule out the possibility of an indirect effect, we
performed a series of experiments using various receptor antag-
onists. The effect of DHPG was not mediated by iGluRs,
GABAaR, GABAbR, A1R, A2AR, nAChRs, or mAChRs. A mixture
containingalloftheseantagonistsalsofailedtopreventtheeffect
ofDHPG.Althoughwecouldnotcompletelyexcludeallindirect
effects, the results are consistent with the possibility that DHPG
depressesevokedDAreleasebyactingdirectlyonthemGluR1on
theDAterminals.Therehasbeennopreviousreportofapresyn-
apticactionbythisreceptorinventralmidbrainDAneurons,but
it is highly expressed in ventral midbrain DA cell bodies and
dendrites (Hubert et al., 2001), in which it acts to depress neuro-
nal excitability (Fiorillo and Williams, 2000). Although mGluR5
has been implicated in the modulation of DA release (Page et al.,
2001), we found that the mGluR5 antagonist MPEP failed to
abolish the DA depression induced by DHPG and that the effect
wasmaintainedinmGluR5-deficientmice.Weconcludethatthe
depression was mediated through mGluR1 or unidentified
mGluRs with similar properties. A recent study reports that,
whereas mGluR5 is almost exclusively found postsynaptically in
striatalneurons,mGluR1istheonlyglutamatereceptorobserved
byultrastructuralimmunolabelingonDAterminals(Paguetand
Smith, 2003).
DepressionofevokedDAreleaseby HFS
Corticostriatal firing patterns are complex in anesthetized rats
with firing frequencies ranging from 5t o100 Hz during the
upstates(Sternetal.,1997),butwhetherglutamatespillovercan
occurandstimulatemGluR1duringnormalcorticostriatalfiring
patternsremainsunknown.Nevertheless,extrasynapticdiffusion
of glutamate to activate iGluRs has been demonstrated in the
hippocampus and cerebellum (Dzubay and Jahr, 1999). Because
mGluRs display higher affinity for glutamate than ionotropic
receptors (Conn and Pin, 1997), it is likely that a relatively small
amount of extrasynaptic spilled-over glutamate might activate
mGluRs. Our results suggest that a small amount of glutamate
spillover occurs during HFS, leading to mGluR1 activation. This
also explains the efficacy of 100 M THA in this study. Whereas
bath application of EAAT blockers or DHPG usually requires
6–10mintoreachthemaximalinhibition(mainlyattributableto
substation of the perfusion fluid), the time course of HFS-
mediateddepressionwassurprising,becausealthoughitwasrap-
idlyinitiated,itreachedamaximumvaluewithin5min.Itmaybe
that mGluR activation stimulates more than one downstream
pathwaythatmodulatesevokedDArelease.Forinstance,changes
in DA synthesis mediated by second-messenger systems may
haveslowlydevelopingeffectsviachangesinquantalsize(Pothos
etal.,1998)orviaCa
2-dependentformsofmodulationofCa
2
channels (McCool et al., 1998).
Implicationsforphysiological relevance
Our results suggest that, when glutamate spills over from corti-
costriatal synapses, there is a consequent depression of DA neu-
rotransmission.TheDAreleasedfromnigrostriatalsynapses,un-
der some conditions, acts on presynaptic corticostriatal D2 DA
receptors to depress glutamatergic afferentation (Cepeda et al.,
2001). Our results thus suggest a reciprocal depression of gluta-
mateandDAneurotransmissiononeachotherunderconditions
inwhichsynapticspilloverisadequatetostimulatedistalpresyn-
aptic group I mGluRs or D2 receptors, respectively.
Recent studies suggest that interactions between nigrostriatal
DA activity and striatal group I mGluRs activation determine
whether a given tetanus results in corticostriatal long-term de-
pressionorlong-termpotentiation(Centonzeetal.,2001;Gubel-
lini et al., 2001; Sung et al., 2001). Thus, the reciprocal interplay
betweenthesetwoafferentpathwaysinthestriatummayunderlie
long-term plastic modulation of striatal synapses. It should be
noted that, although the effects of D2 autoreceptors last only
for  1 sec (Benoit-Marand et al., 2001; Phillips et al., 2002;
Schimtz et al., 2002), the effect of mGluR1 activation appear to
last for several minutes, perhaps underlying the factors in the
10590 • J.Neurosci.,November19,2003 • 23(33):10585–10592 ZhangandSulzer• GlutamateSpilloverInhibitsDopamineReleasetiming of motor learning and the development of forms of be-
havioral reinforcement.
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